Takayasu arteritis revisited: Current diagnosis and treatment

International Journal of Cardiology

Volumn 168, Issue 1, 2013, Pages 3-10

  Isobe, Mitsuaki ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Aortitis; Arteritis; Biological agent; Endovascular treatment; Immunosuppression; Inflammation

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; ETANERCEPT; FLUORODEOXYGLUCOSE F 18; GADOLINIUM; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RITUXIMAB; STEROID; TACROLIMUS; TOCILIZUMAB;

AORTA ARCH SYNDROME; AUTOIMMUNITY; BLOOD ANALYSIS; BYPASS SURGERY; CLINICAL FEATURE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG MEGADOSE; DRUG SUBSTITUTION; ECHOGRAPHY; ENDOVASCULAR SURGERY; GENETIC RISK; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; REVIEW; RHEUMATOID ARTHRITIS; VASCULITIS;

AORTITIS; ARTERITIS; BIOLOGICAL AGENT; ENDOVASCULAR TREATMENT; IMMUNOSUPPRESSION; INFLAMMATION;

ANIMALS; BIOLOGICAL PRODUCTS; ENDOVASCULAR PROCEDURES; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; POSITRON-EMISSION TOMOGRAPHY; TAKAYASU ARTERITIS; TREATMENT OUTCOME;

EID: 84883749675     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.01.022     Document Type: Review

References (87)

1. M. Takayasu A case of paradoxical changes in the central retinal arteries J Jpn Ophthalmol Soc 12 1908 554 555 [in Japanese]
2. F. Numano, M. Okawara, H. Inomata, and Y. Kobayashi Takayasu's arteritis Lancet 356 2000 1023 1025
3. K. Shimizu, and K. Sano Pulseless disease J Neuropathol Clin Neurol 1 1951 37 47
4. H. Ueda, Y. Saito, Y. Ito, H. Yamaguchi, M. Sugiura, and S. Morooka Immunological studies of aortitis syndrome Jpn Heart J 8 1967 4 18
5. D. Tezuka, G. Haraguchi, and T. Ishihara Role of FDG-PET/CT and utility of maximum standard uptake value in Takayasu arteritis: sensitive detection of recurrence J Am Coll Cardiol Imaging 5 2012 422 429
6. T. Ishihara, G. Haraguchi, T. Kamiishi, D. Tezuka, H. Inagaki, and M. Isobe Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker J Am Coll Cardiol 57 2011 1712 1713
7. Japanese Circulation Society Joint working Group Guideline for management of vasculitis syndrome (Japanese Circulation Society 2008) Circ J 75 2011 474 503
8. H. Ohigashi, G. Haraguchi, and M. Konishi Improved prognosis of Takayasu arteritis in the last decade: comprehensive analysis of 106 patients Circ J 76 2012 1004 1011
9. F. Numano, and Y. Kobayashi Takayasu arteritis and Buerger Disease IV Int J Cardiol 75 2000 1 192 [Suppl.]
10. F. Numano Hereditary factors of Takayasu arteritis Heart Vessels 7 1992 68 72 [Suppl.]
11. Y. Seko, S. Minota, and A. Kawasaki Perforin-secreting killer cell infiltration and expression of a 65-kD heat-shock protein in aortic tissue of patients with Takayasu's arteritis J Clin Invest 93 1994 750 758
12. M.C. Cid, M. Cebrian, and C. Font Cell adhesion molecules in the development of inflammatory infiltrates in giant cell arteritis: inflammation-induced angiogenesis as the preferential site of leukocyte-endothelial cell interactions Arthritis Rheum 43 2000 184 194
13. C.M. Weyand, and J.J. Goronzy Medium- and large-vessel vasculitis N Engl J Med 349 2003 160 169
14. F. Numano Vasa vasoritis, vasculitis and atherosclerosis Int J Cardiol 75 2000 S1 S8
15. T. Ishihara, G. Haraguchi, and D. Tezuka Diagnosis and assessment of Takayasu arteritis by multiple biomarkers Circ J 77 2013 477 483
16. C. Yutani Pathology of arteritis syndrome Rinsho Byori 21 2003 1007 1013 [in Japanese]
17. Y. Kobayashi, and F. Numano Takayasu arteritis H. Hashimoto, Vasculitis 2001 Asakura Publishing Tokyo 192 198 [in Japanese]
18. N. Ohbuchi, M. Takahashi, and T. Nouchi Identification of MICA alleles with a long Leu-repeat in the transmembrane region and no cytoplasmic tail due to a frameshift-deletion in exon 4 A Tissue Antigens 57 2001 520 535
19. M. Yoshida, A. Kimura, K. Katsuragi, F. Numano, and T. Sasazuki DNA typing of HLA-B gene in Takayasu's arteritis Tissue Antigens 42 1993 87 90
20. A. Kimura, H. Kitamura, Y. Date, and F. Numano Comprehensive analysis of HLA genes in Takayasu arteritis in Japan Int J Cardiol 54 1996 S61 [Suppl.]
21. H. Kitamura, Y. Kobayashi, A. Kimura, and F. Numano Association of clinical manifestations with HLA-B alleles in Takayasu arteritis Int J Cardiol 66 1998 S121 S126 [Suppl.]
22. S. Saito, S. Ota, E. Yamada, H. Inoko, and M. Ota Alleles frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population Tissue Antigens 56 2000 522 529
23. C. Takamura, H. Ohigashi, Y. Ebana, and M. Isobe A new HLA risk allele in Japanese patients with Takayasu arteritis Circ J 76 2012 1697 1702
24. G.S. Hoffman, and A.E. Ahmed Surrogate markers of disease activity in patients with Takayasu arteritis. A preliminary report from the International Network for the Study of the Systemic Vasculitis (INSSYS) Int J Cardiol 66 Suppl. 1 1998 S191 S195
25. G.S. Kerr Takayasu's arteritis Rheum Dis Clin North Am 21 1995 1041 1058
26. A. Matsuyama, N. Sakai, and M. Ishigami Matrix metalloproteinases as novel disease markers in Takayasu arteritis Circulation 108 2003 1469 1473
27. M. Norrris, E. Daina, S. Gamba, S. Bonazzola, and G. Remuzzi Interleukin-6 and RANTES in Takayasu arteritis: a guide for therapeutic decisions? Circulation 100 1999 55 60
28. M.C. Park, S.W. Lee, Y.B. Park, and S.K. Lee Serum cytokine profiles and their correlations with disease activity in Takayasu's arteritis Rheumatology (Oxford) 45 2006 545 548
29. N. Mahajan, V. Dhawan, S. Malik, and S. Jain Serum levels of soluble receptor for advanced glycation end products (sRAGE) in Takayasu's arteritis Int J Cardiol 145 2010 589 591
30. T. Koga, Y. Nishino, and J. Makiyama Serum amyloid A is a useful marker to evaluate the disease activity of Takayasu's arteritis Rheumatol Int 30 2010 561 563
31. S. Noguchi, F. Numano, M.B. Gravanis, and J.N. Wilcox Increased levels of soluble forms of adhesion molecules in Takayasu arteritis Int J Cardiol 66 1998 S23 S33
32. M. Sharif, C. Salisbury, D.J. Taylor, and J.R. Kirwan Changes in biochemical markers of joint tissue metabolism in a randomized controlled trial of glucocorticoid in early rheumatoid arthritis Arthritis Rheum 41 1998 1203 1209
33. V. Vidal Alles, B. Bottazzi, G. Peri, J. Golay, M. Introna, and A. Mantovani Inducible expression of PTX3, a new member of the pentraxin family, in human mononuclear phagocytes Blood 84 1994 3483 3493
34. G.W. Lee, A.R. Goodman, T.H. Lee, and J. Vilcek Relationship of TSG-14 protein to the pentraxin family of major acute phase proteins J Immunol 153 1994 3700 3707
35. N. Kotooka, T. Inoue, and D. Fujimatsu Pentraxin3 is a novel marker for stent-induced inflammation and neointimal thickening Atherosclerosis 197 2008 368 374
36. K. Inoue, A. Sugiyama, and P.C. Reid Establishment of a high sensitivity plasma assay for human pentraxin3 as a marker for unstable angina pectoris Arterioscler Thromb Vasc Biol 27 2007 161 167
37. L. Dagna, F. Salvo, and M. Tiraboschi Pentraxin-3 as a marker of disease activity in Takayasu arteritis Ann Intern Med 155 2011 425 433
38. K. Maksimowics-McKinnon, T.M. Clark, and G.S. Hoffman Limitation of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients Arthritis Rheum 56 2007 1000 1009
39. R.P. Steeds, and R. Mohiaddin Takayasu arteritis: role of cardiovascular magnetic imaging Int J Cardiol 109 2006 1 6
40. N.G. Keenan, J.C. Mason, and A. Maceira Integrated cardiac and vascular assessment in Takayasu arteritis by cardiovascular magnetic resonance Arthritis Rheum 60 2009 3501 3508
41. M. Desai, J.H. Stone, T.K.F. Foo, D.B. Hellmann, J.A.C. Lima, and D.A. Bluemke Delayed contrast-enhanced MRI of the aortic wall in Takayasu's arteritis: initial experience Am J Roentgenol 184 2005 1427 1431
42. L. Jiang, D. Li, F. Yan, X. Dai, Y. Li, and L. Ma Evaluation of Takayasu arteritis activity by delayed contrast-enhanced magnetic resonance imaging Int J Cardiol 155 2012 262 267
43. M. Papa, F. De Cobelli, and E. Baldissera Takayasu arteritis: intravascular contrast medium for MR angiography in the evaluation of disease activity Am J Roentgenol 198 2012 W279 W284
44. J.H. Park, J.W. Chung, K.W. Lee, Y.B. Park, and M.C. Han CT angiography of Takayasu arteritis: comparison with conventional angiography J Vasc Interv Radiol 8 1997 393 400
45. S. Yoshida, H. Akiba, and M. Tamakawa The spectrum of findings in supra-aortic Takayasu's arteritis as seen on spiral CT angiography and digital subtraction angiography Cardiovasc Intervent Radiol 24 2001 117 121
46. M.E. Soto, G. Melendez-Ramifez, and R. Kimura-Hayama Coronary CT angiography in Takayasu arteritis J Am Coll Cardiol Img 4 2011 958 966
47. 18F] FDG PET and MRI Eur J Nucl Med Mol Imaging 30 2003 730 736
48. 18F-FDG PET coregistered with enhanced CT J Nucl Med 46 2005 917 922
49. 18F-fluorodeoxyglucose positron emission tomography scanning a reliable way to assess disease activity in Takayasu arteritis? Arthritis Rheum 60 2009 1193 1200
50. J.H.F. Rudd, K.S. Myers, and S. Bansilal Atherosclerosis inflammation imaging with 18F-FDG PET: carotid, iliac, and femoral uptake reproducibility, quantification methods, and recommendations J Nucl Med 49 2008 871 878
51. T.D. Ruddy, and G.R. Small PET imaging of aortic atherosclerosis: is combined imaging of plaque anatomy and function an amaranthine quest or conceivable reality? J Nucl Cardiol 18 2011 717 728
52. H. Maeda, N. Handa, and M. Matsumoto Carotid lesions detected by B-mode ultrasonography in Takayasu's arteritis: "macaroni sign" as an indicator of the disease Ultrasound Med Biol 17 1991 695 701
53. W.A. Schmidt, A. Nerenheim, E. Seipelt, C. Poehis, and E. Gromnica-Ihle Diagnosis of early Takayasu arteritis with sonography Rheumatology (Oxford) 41 2002 496 502
54. S. Seth, N.K. Goyal, and P. Jagia Carotid intima-medial thickness as a marker of disease activity in Takayasu's arteritis Int J Cardiol 108 2006 385 390
55. J.H. Shelhamer, D.J. Volkman, J.E. Parrillo, T.J. Lawley, M.R. Johnston, and A.S. Fauci Takayasu's arteritis and its therapy Ann Intern Med 103 1985 121 126
56. G.S. Kerr, C.W. Hallahan, and J. Giordano Takayasu arteritis Ann Intern Med 120 1994 919 929
57. C. Mukhtyar, M.C. GuillevinL Cid, and B. Dasgupta EULAR recommendations for the management of large vessel vasculitis Ann Rheum Dis 68 2009 318 323
58. J.C. Mason Takayasu arteritis - advances in diagnosis and management Nat Rev Rheumatol 6 2010 406 415
59. G.S. Hoffman, R.Y. Leavitt, G.S. Kerr, M. Rottem, M.C. Sneller, and A.S. Fauci Treatment of glucocorticoid-resistant or relapsing Takayasu arteritis with methotrexate Arthritis Rheum 37 1994 578 582
60. A.K. Valsakumar, U.C. Valappil, V. Jorapur, N. Garg, S. Nityanand, and N. Sinha Role of immunosuppressive therapy on clinical, immunological, and angiographic outcome in active Takayasu's arteritis J Rheumatol 30 2003 1793 1798
61. E. Daina, A. Shieppati, and G. Remuzzi Mycophenolate mofetil for the treatment of Takayasu arteritis: report of three cases Ann Intern Med 130 1999 422 426
62. G.S. Hoffman, P.A. Merkel, R.D. Brasington, D.J. Lenschow, and P. Liang Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu Arteritis Arthritis Rheum 50 2004 2296 2304
63. E.S. Molloy, C.A. Langford, T.M. Clark, E. Gota, and G.S. Hoffman Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up Ann Rheum Dis 67 2008 1567 1569
64. J. Schmidt, T.A. Kermani, A.K. Bacani, C.S. Crowson, E.L. Matteson, and K.J. Warrington Tumor necrosis factor inhibitors in patients with Takayasu arteritis: experience from a referral center with long-term follow up Arthritis Care Res (Hoboken) 64 7 2012 1079 1083
65. Z.T. Karageorgaki, C.P. Mavragani, M.A. Papathanasiou, and F.N. Skopouli Infliximab in Takayasu arteritis: a safe alternative? Clin Rheumatol 26 2007 984 987
66. G. Filocamo, A. Buoncompagni, and S. Viola Treatment of Takayasu's arteritis with tumor necrosis factor antagonists J Pediatr 153 2008 432 434
67. U. Kaneko, T. Kishi, and M. Kikuchi Infliximab therapy for three adolescent patients with refractory Takayasu's arteritis Nihon Rinsho Meneki Gakkai Kaishi 33 2010 317 323 [in Japanese]
68. G. Nunes, F.S. Neves, F.M. Melo, G.R.W. de Castro, A.F. Zimmermann, and I.A. Pereira Takayasu arteritis: anti-TNF therapy in a Brazilian setting Rev Bras Rheumatol 50 2010 291 298
69. A. Mekinian, A. Neel, and J. Sibilia Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicenter study Rheumatology (Oxford) 51 2011 882 886
70. C. Comarmond, E. Plaisier, and K. Dahan Anti TNF-α in refractory Takayasu's arteritis: cases series and review of the literature Autoimmun Rev 11 9 2012 678 684
71. N. Nishimoto, H. Nakahara, N. Yoshio-Hoshino, and T. Mima Successful treatment of a patient with Takayasu arteritis using a humanized anti-interleukin-6 receptor antibody Arthritis Rheum 58 2008 1197 1200
72. M.N. Seitz, S. Reichenbach, H.M. Bonel, S. Adler, F. Wermelinger, and P.M. Villiger Rapid induction of remission in large vessel vasculitis by IL-6 blockade. A case series Swiss Med Wkly 141 2011 w13156
73. C. Salvarani, L. Magnani, and M. Catanoso A novel therapy for patients with large-vessel vasculitis Rheumatology (Oxford) 51 1 2012 151 156
74. S. Unizony, L. Arias-Urdaneta, and E. Miloslavsky Tocilizumab for the treatment of large-vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumatica Arthritis Care Res (Hoboken) 64 2012 1720 1729
75. B.F. Hoyer, I.M. Mumtaz, and K. Loddenkemper Takayasu arteritis is characterized by disturbances of B cell homeostasis and responds to B cell depletion therapy with rituximab Ann Rheum Dis 71 2012 75 79
76. M. Ramos-Casals, P. Brito-Zerón, M.J. Soto, M.J. Cuadrado, and M.A. Khamashta Autoimmune disease induced by TNF-targeted therapies Best Pract Res Clin Rheumatol 22 2008 847 861
77. T. Miyata, O. Sato, H. Koyama, H. Shigematsu, and Y. Tada Long-term survival after surgical treatment of patients with Takayasu's arteritis Circulation 108 2003 1474 1480
78. J. Andrews, and J.C. Mason Takayasu's arteritis - recent advances in imaging offer promise Rheumatology (Oxford) 46 2007 6 15
79. M.A. Qureshi, Z. Martin, and R.K. Greenberg Endovascular management of patients with Takayasu arteritis: stents versus stent grafts Semin Vasc Surg 24 2011 44 52
80. C.E. Fields, T.C. Bower, and L.T. Cooper Takayasu's arteritis: operative results and influence of disease activity J Vasc Surg 43 2006 64 71
81. M.C. Park, S.W. Lee, Y.B. Park, S.K. Lee, D. Choi, and W.H. Shim Post-interventional immunosuppressive treatment and vascular restenosis in Takayasu's arteritis Rheumatology (Oxford) 45 2006 600 605
82. H. Ogino, H. Matsuda, and K. Minatoya Overview of late outcome of medical and surgical treatment for Takayasu arteritis Circulation 118 2008 2738 2747
83. P. Liang, M. Tan-Ong, and G.S. Hoffman Takayasu's arteritis: vascular interventions and outcomes J Rheumatol 31 2004 102 106
84. J.W. Son, K.K. Koh, Q. Dang, I.S. Choi, and E.K. Shin Recurrent restenosis following stent and rotational atherectomy of coronary artery stenosis in Takayasu's arteritis Int J Cardiol 65 1998 295 300
85. K. Yokota, M. Shimpo, and T. Iwata A case of Takayasu arteritis with repeated coronary artery restenosis after drug-eluting stent implantation successfully treated with a combination of steroids Intern Med 51 2012 739 743
86. Y. Furukawa, T. Tamura, and M. Toma Sirolimus-eluting stent for in-stent restenosis of left main coronary artery in Takayasu arteritis Circ J 69 2005 752 755
87. K. Lee, W.C. Kang, and T. Ahn Long-term outcome of drug-eluting stent for coronary artery stenosis in Takayasu's arteritis Int J Cardiol 145 2010 532 535